ArticleCancer informatics2022

Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment.

Precious A Akinnusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.